Short Interest in Nanovibronix, Inc. (NASDAQ:FEED) Decreases By 85.1%

Nanovibronix, Inc. (NASDAQ:FEED) was the target of a large drop in short interest in the month of June. As of June 30th, there was short interest totaling 60,839 shares, a drop of 85.1% from the June 15th total of 409,683 shares. Currently, 1.0% of the company’s shares are sold short. Based on an average daily trading volume, of 251,416 shares, the days-to-cover ratio is currently 0.2 days.

Analyst Upgrades and Downgrades

FEED has been the topic of a number of research reports. Wall Street Zen upgraded Nanovibronix from a “strong sell” rating to a “sell” rating in a report on Tuesday, April 28th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Nanovibronix in a report on Friday, April 24th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has an average rating of “Sell”.

Insiders Place Their Bets

In related news, insider Christian Michael Glibert sold 210,000 shares of Nanovibronix stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $0.69, for a total value of $144,900.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 1.40% of the company’s stock.

Nanovibronix Stock Down 1.6%

NASDAQ FEED traded down $0.01 on Friday, reaching $0.53. The company had a trading volume of 523,274 shares, compared to its average volume of 362,778. Nanovibronix has a 1 year low of $0.42 and a 1 year high of $17.40. The firm’s 50-day moving average is $0.84. The firm has a market capitalization of $3.22 million, a price-to-earnings ratio of -0.06 and a beta of 1.56.

Nanovibronix (NASDAQ:FEED) last posted its quarterly earnings data on Monday, May 18th. The company reported ($6.88) earnings per share (EPS) for the quarter. Nanovibronix had a negative net margin of 923.20% and a negative return on equity of 54.25%. The firm had revenue of $0.65 million for the quarter.

Nanovibronix Company Profile

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.